Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies

Cell Mol Life Sci. 2023 Mar 10;80(4):85. doi: 10.1007/s00018-023-04725-8.

Eleonora Orlando^#^{1

2}, Matúš Medo^#^{1

2}, Ariel Bensimon³, Aurélie Quintin^{1

2}, Rahel Riedo^{1

2}, Selina M Roth^{1

2}, Carsten Riether^{4

5}, Thomas M Marti^{6

7}, Daniel M Aebersold^{1

2}, Michaela Medová^#^{1

2}, Ruedi Aebersold^#^{8

9}, Yitzhak Zimmer^#^{10

11}

¹ Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
² Department for BioMedical Research, Radiation Oncology, University of Bern, MEM-E807, Murtenstrasse 35, 3008, Bern, Switzerland.
³ Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, HPM H25, Otto-Stern-Weg 3, 8093, Zurich, Switzerland.
⁴ Tumorimmunology, Department for BioMedical Research, University of Bern, Bern, Switzerland.
⁵ Department of Medical Oncology, Inselspital, University Hospital and University of Bern, 3010, Bern, Switzerland.
⁶ Thoracic Surgery, Department for BioMedical Research, University of Bern, Bern, Switzerland.
⁷ Division of General Thoracic Surgery, Inselspital Bern University Hospital, Bern, Switzerland.
⁸ Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, HPM H25, Otto-Stern-Weg 3, 8093, Zurich, Switzerland. [email protected].
⁹ Faculty of Science, University of Zürich, Zurich, Switzerland. [email protected].
¹⁰ Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. [email protected].
¹¹ Department for BioMedical Research, Radiation Oncology, University of Bern, MEM-E807, Murtenstrasse 35, 3008, Bern, Switzerland. [email protected].

^# Contributed equally.

No abstract available

Publication types